Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Vertex’s midstage data amplify kidney disease market opportunity
The positive phase 2b data boost Vertex's efforts to expand beyond the population targeted in a pivotal trial.
Nick Paul Taylor
Sep 22, 2026 10:09am
Frazier Life Sciences nets $1.1B in long-running biotech fund
Sep 10, 2026 9:44am
Invivyd's chair adds CEO role ahead of readout—Chutes & Ladders
Sep 4, 2026 8:30am
Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex
Aug 10, 2026 9:38am
Vertex’s latest autoimmune TCE play involves $28M to AbCellera
Jul 29, 2026 8:20am
Eli Lilly takes top spot on new biopharma productivity ranking
Jul 28, 2026 1:00pm
